Uric acid and the cardiovascular profile of African and Caucasian men

I M Palmer1, A E Schutte, H W Huisman

  • 1Hypertension in Africa Research Team (HART), Northwest University, Potchefstroom, South Africa.

Insights

African men have lower uric acid (UA) levels than Caucasian men, yet still show a strong link between UA and vascular resistance. This suggests UA may contribute to hypertension risk in Africans.

Area of Science:

  • Cardiovascular Disease Research
  • Human Physiology
  • Ethnic Health Disparities

Background:

  • The African population faces a high risk of hypertension and cardiovascular disease (CVD).
  • Elevated uric acid (UA) levels are frequently linked to CVD, making it a key area for research.
  • Understanding ethnic differences in risk factors like UA is crucial for targeted prevention strategies.

Purpose of the Study:

  • To investigate ethnic variations in uric acid (UA) levels between African and Caucasian men.
  • To examine the associations between UA levels and cardio-metabolic variables across ethnic groups.
  • To determine how these relationships differ, particularly concerning hypertension risk.

Main Methods:

  • A cross-sectional study involving 87 African men and 121 Caucasian men.
  • Measurement of uric acid (UA) levels and various cardio-metabolic variables, including waist circumference and triglycerides.
  • Statistical analyses including correlation, multiple regression, and analysis of variance (ANOVA) across UA tertiles.

Main Results:

  • African men exhibited significantly lower mean uric acid (UA) levels compared to Caucasian men (353±87.7 vs 401±98.2; P<0.01).
  • Waist circumference and triglycerides showed strong correlations with UA in both ethnic groups.
  • An independent correlation between UA and total peripheral resistance (TPR) was observed exclusively in African men (r=0.23; P=0.04), with TPR increasing across UA tertiles.

Conclusions:

  • Despite lower overall uric acid (UA) levels, African men demonstrate a significant independent relationship between UA and vascular resistance (TPR).
  • This distinct association suggests a potential mechanism contributing to the high prevalence of hypertension in the African population.
  • Further research into UA's role in vascular health disparities is warranted.

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System III: Serum Lipid Profile01:25

Blood Studies for Cardiovascular System III: Serum Lipid Profile

Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration01:28

Drug Dosing in Renal Diseases: Estimation of Glomerular Filtration Rate Based on Serum Creatinine Concentration

Glomerular filtration rate (GFR) can be estimated from serum creatinine using the modification of diet in renal disease (MDRD) formula or the chronic kidney disease–epidemiology collaboration (CKD–EPI) equation. Both methods are widely used in clinical practice to assess kidney function and guide treatment decisions.The MDRD equation does not require weight or height measurements and is normalized to the body surface area of 1.73 m², considered the average adult surface area. This equation is...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...